Glooko is a global digital health company focused on helping clinicians address the growing challenges of glycemic safety and diabetes management across the care continuum. Glooko is uniquely positioned to be the enterprise partner of choice for healthcare providers seeking to reduce glycemic risk, improve safety, and support overburdened clinical teams with coordinated expertise across both outpatient and inpatient care settings.
Glooko XT, our remote patient monitoring solution in France, is tailored for the French healthcare landscape, complies with French regulations on health data management, and prioritizes patient privacy and data security.
* Number of patients include patients over time who have used the Glooko® System, GlookoXT ®, and diasend® System since the respective launch of each product.
** Number of clinics includes clinics using the Glooko® System, GlookoXT®, and diasend® System since the respective launch of each product.
Glooko’s connected care platform enables hospitals, health systems, and clinics around the world to remotely monitor patients living with diabetes, integrate data from a variety of diabetes and health monitoring devices, and enhance care through more frequent interactions.
We’re proud to support organizations around the world working to improve the lives of people living with diabetes, including the American Diabetes Association’s (ADA) Tour de Cure®.
Our team is committed to raising funds and awareness for diabetes research, education, and advocacy, furthering our mission to improve the lives of people with diabetes and the clinicians who care for them.
Help us transform diabetes care
We partner with diabetes device makers, pharmaceutical companies, and digital health innovators to improve diabetes care and management.
We’re thrilled to journey to Nashville from March 29 to April 1 for the Society of Hospital Medicine Converge Conference 2026, the premier gathering for hospital medicine professionals. As the healthcare landscape shifts toward a system-level approach to glycemic...
Inpatient glycemic safety is no longer just a clinical goal — it’s now a visible, system-level performance measure. With CMS requiring eCQM reporting for severe hypoglycemia and hyperglycemia as part of the Inpatient Quality Reporting (IQR) program, variations in...
In the Glooko Mobile 6.15 release, we introduced a refreshed Glooko Mobile App experience with the busy daily routine of people living with diabetes in mind. The free app, proven to improve glycemic outcomes in 2 months, helps people living with diabetes better manage...
